2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-[[4-(6-methyl-2-benzothiazolyl)phenyl]azo]-, (1-methyl-1H-imidazolyl)methyl derivs.methanesulfonates (84852-17-5)
Identification |
Properties |
Safety Data |
|
|
Other Product
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[[4-(6-methyl-2-benzothiazolyl)phenyl]azo]-,mono[(1-methyl-1H-imidazolyl)methyl] deriv. (9CI)
- 5-[[4-(6-methyl-2-benzothiazolyl)phenyl]azo]barbituric acid, mono[(4-methyl-1H-imidazolyl)methyl] derivative, monomethanesulphonate
- methoxyacetic acid, compound with 5-[[4-(6-methylbenzothiazol-2-yl)phenyl]azo]pyrimidine-2,4,6-(1H,3H,5H)-trione mono[(1-methyl-1H-imidazolyl)methyl] derivative (1:1)
- Pyrazolo[5,1-b]quinazoline-9(1H)-one,2-methyl-3-[[4-(6-methyl-2-benzothiazolyl)phenyl]azo]-,mono[(4-methyl-1H-imidazolyl)methyl] monosulfo deriv. (9CI)
- 5-((4-(6-Methylbenzothiazol-2-yl)phenyl)azo)barbituric acid, mono((1-methyl-1H-imidazolyl)methyl) derivative, monoacetate
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[[[4-[(1,2-dihydro-4-methyl-2-oxo-6-quinolinyl)azo]-2,5-dimethoxyphenyl]imino]methyl]-
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[[[4-[(4-chloro-2-methylphenyl)azo]phenyl]imino]methyl]-
- sulphamic acid, compound with 5-[[4-(6-methylbenzothiazol-2-yl)phenyl]azo]barbituric acid, mono[(1-methyl-1H-imidazolyl)methyl] derivative (1:1)
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[[[4-[(5-chloro-2-methylphenyl)azo]-2,5-dimethylphenyl]imino]methyl]-
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[2-[2-[4-(dimethylamino)phenyl]ethenyl]-6-methyl-4H-pyran-4-ylidene]-1,3-dimethyl-
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-3-methyl-1-[2-(4-morpholinyl)ethyl]-5-phenyl-
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[[4-(diethylamino)phenyl]methylene]-1-[(2-hydroxyethoxy)methyl]-
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[[4-(dimethylamino)phenyl]methylene]-1-[(2-hydroxyethoxy)methyl]-
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[3-[4-(dimethylamino)phenyl]-1-methyl-2-propenylidene]-1,3-diphenyl-
- 2-methyl-3-[[4-(6-methylbenzothiazol-2-yl)phenyl]azo]pyrazolo[5,1-b]quinazolin-9(1H)-one, mono[(4-methyl-1H-imidazolyl)methyl] derivative
- 2-methyl-3-[[4-(6-methylbenzothiazol-2-yl)phenyl]azo]pyrazolo[5,1-b]quinazolin-9(1H)-one, mono[(4-methyl-1H-imidazolyl)methyl] derivative, monoacetate
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[[[4-[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)azo]-2,5-dimethylphenyl]imino]methyl]-
- 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-[[4-(dimethylamino)phenyl]methyl]-
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[[[4-[(9,10-dihydro-9,10-dioxo-1-anthracenyl)azo]phenyl]imino]methyl]-
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-methyl-5-[(6-methyl-2-pyridinyl)methyl]-